Personal information
Biography
Andreas studied chemistry at the Ludwig-Maximilians-University of Munich (LMU, Germany), studied chemistry at the Ludwig-Maximilians University of Munich, Germany, and received his M.Sc. degree in 2010.
In 2010 Andreas joined the research group of Frank M. Boeckler (Laboratory for Molecular Design and Pharmaceutical Biophysics, at the University of Tuebingen, Germany) for his Ph.D. thesis where he studied the applicability of halogen bonds for molecular drug design. He characterised (theoretical and experimental) possible binding patterns to address the amino acids Methionine, Histidine, protein backbone, and Aspartate & Glutamate. Furthermore he could find a bivalent halogen-chalcogen binding mechanism through halogen bonding in the kinase JNK3. Such a binding mechanism can only happen to a few classes of kinases which might help to identifiy new ligands inducing such a binding pattern. His Ph.D. work has led to 11 publications (two first author publications).
In 2016 Andreas joined the research group of Prof. Bornberg-Bauer at the Institute of Evolution and Biodiversity at the University of Muenster, where he studies the structure and function of de novo proteins from mouse, drosophila, and homo sapiens. Since September 2018 he is Project manager according to the gene technology act (§ 15 GenTSV) and since January 2020 Safety manager for laboratories at IEB.
From August 2019 until October 2019 he joined the Lab of Prof. Ylva Ivarsson, BMC, Uppsala, Sweden, to learn and measure his de novo proteins via phage display in order to identify possible binding patterns through an EMBO Short-term scholarship.
Activities
Employment (5)
Education and qualifications (3)
Professional activities (2)
Funding (1)
8268